ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
29 FIRST LINE CHEMOTHERAPY WITH DOCETAXEL/GEMCITABINE/TRASTUZUMAB (GOIM 2611) IN PATIENT WITH ADVANCED BREAST CANCER HER-2 POS: A CASE REPORT OF EARLY AND PROLONGED RESPONSE
Cancer Treatment Reviews
◽
10.1016/s0305-7372(10)70055-4
◽
2010
◽
Vol 36
◽
pp. S103
Author(s):
F. Riccardi
◽
M. Rizzo
◽
G. Carrillo
◽
F. De Michele
◽
S. Daniele
◽
...
Keyword(s):
Breast Cancer
◽
Case Report
◽
Advanced Breast Cancer
◽
Advanced Breast
◽
First Line
◽
Her 2
◽
Prolonged Response
◽
Line Chemotherapy
Download Full-text
Related Documents
Cited By
References
346 Taxol or doxorubicin as first line chemotherapy in advanced breast cancer (ABC). A prospective randomized phase II study with crossover
European Journal of Cancer
◽
10.1016/0959-8049(95)95599-2
◽
1995
◽
Vol 31
◽
pp. S75
◽
Cited By ~ 1
Author(s):
R. Paridaens
◽
P. Bruning
◽
F. Calabresi
◽
A. Awada
◽
J.A. Roy
◽
...
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Advanced Breast
◽
First Line
◽
Randomized Phase Ii
◽
Line Chemotherapy
Download Full-text
Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer)
Annals of Oncology
◽
10.1093/annonc/mdi056
◽
2005
◽
Vol 16
(2)
◽
pp. 253-258
◽
Cited By ~ 59
Author(s):
L. Del Mastro
◽
F. Perrone
◽
L. Repetto
◽
L. Manzione
◽
V. Zagonel
◽
...
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Cancer Patients
◽
Phase Ii
◽
Phase Ii Study
◽
Advanced Breast
◽
Weekly Paclitaxel
◽
Breast Cancer Patients
◽
First Line
◽
Line Chemotherapy
Download Full-text
Phase I, dose-finding study of capecitabine in combination with docetaxel and epirubicin as first-line chemotherapy for advanced breast cancer
Annals of Oncology
◽
10.1093/annonc/mdf056
◽
2002
◽
Vol 13
(4)
◽
pp. 546-552
◽
Cited By ~ 12
Author(s):
M. Venturini
◽
L. Del Mastro
◽
O. Garrone
◽
C. Angiolini
◽
M. Merlano
◽
...
Keyword(s):
Breast Cancer
◽
Phase I
◽
Advanced Breast Cancer
◽
Advanced Breast
◽
Dose Finding
◽
First Line
◽
Finding Study
◽
Dose Finding Study
◽
Line Chemotherapy
Download Full-text
Should paclitaxel be combined with epirubicin or carboplatin as first-line chemotherapy for advanced breast cancer?
Nature Clinical Practice Oncology
◽
10.1038/ncponc0079
◽
2005
◽
Vol 2
(2)
◽
pp. 80-81
Author(s):
Sudeep Gupta
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Advanced Breast
◽
First Line
◽
Line Chemotherapy
Download Full-text
Mitoxantrone as first-line chemotherapy in advanced breast cancer: results of a collaborative European study
Investigational New Drugs
◽
10.1007/bf00174161
◽
1985
◽
Vol 3
(2)
◽
pp. 139-148
◽
Cited By ~ 13
Author(s):
H. T. Mouridsen
◽
Michael Cornbleet
◽
Robin Stuart-Harris
◽
Ian Smith
◽
Robert Coleman
◽
...
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Advanced Breast
◽
European Study
◽
First Line
◽
Line Chemotherapy
Download Full-text
First-Line Chemotherapy with Liposomal Doxorubicin Plus Cyclofosfamide in Metastatic Breast Cancer: A Case Report of Early and Prolonged Response
International Journal of Immunopathology and Pharmacology
◽
10.1177/039463201302600323
◽
2013
◽
Vol 26
(3)
◽
pp. 773-778
◽
Cited By ~ 1
Author(s):
F. Riccardi
◽
C. Mocerino
◽
C. Barbato
◽
F. Ambrosio
◽
L. Festino
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Case Report
◽
Liposomal Doxorubicin
◽
Metastatic Breast
◽
First Line
◽
Prolonged Response
◽
Line Chemotherapy
Download Full-text
Phase II, multicentre study evaluating cisplatin (P), epirubicin (E) and vinorelbine (V) as first line chemotherapy (CHT) in advanced breast cancer (ABC): A new promise
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.14_suppl.761
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 761-761
Author(s):
S. Barni
◽
M. T. Ionta
◽
R. Labianca
◽
A. Zaniboni
◽
A. Ardizzoia
◽
...
Keyword(s):
Breast Cancer
◽
Multicentre Study
◽
Advanced Breast Cancer
◽
Phase Ii
◽
Advanced Breast
◽
First Line
◽
Line Chemotherapy
Download Full-text
A multicentre phase II study of docetaxel 75 mg m-2 as first-line chemotherapy for patients with advanced breast cancer: report of the Clinical Screening Group of the EORTC
British Journal of Cancer
◽
10.1038/bjc.1996.416
◽
1996
◽
Vol 74
(4)
◽
pp. 650-656
◽
Cited By ~ 58
Author(s):
V Dieras
◽
◽
B Chevallier
◽
P Kerbrat
◽
I Krakowski
◽
...
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Advanced Breast
◽
First Line
◽
Clinical Screening
◽
Multicentre Phase
◽
Line Chemotherapy
Download Full-text
Production of P-glycoprotein from the MDR1 upstream promoter is insufficient to affect the response to first-line chemotherapy in advanced breast cancer
International Journal of Cancer
◽
10.1002/ijc.23149
◽
2007
◽
Vol 122
(5)
◽
pp. 1058-1067
◽
Cited By ~ 15
Author(s):
Selina Raguz
◽
Rebecca A. Randle
◽
Eva R. Sharpe
◽
John A. Foekens
◽
Anieta M. Sieuwerts
◽
...
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Advanced Breast
◽
First Line
◽
P Glycoprotein
◽
Upstream Promoter
◽
Line Chemotherapy
Download Full-text
PP-8-6 Paclitaxel (P) versus doxorublcin (D) as first line chemotherapy (CT) in advanced breast cancer (ABC): A randomized trial with crossover of the EORTC-IDBBC in collaboration with EORTC-ECSG
European Journal of Cancer
◽
10.1016/0959-8049(96)84242-0
◽
1996
◽
Vol 32
◽
pp. 50
◽
Cited By ~ 1
Author(s):
P. Bruning
◽
M.J. Piccart
◽
J. Klijn
◽
T. Gamucci
◽
Z. Kusenda
◽
...
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Randomized Trial
◽
Advanced Breast
◽
First Line
◽
Line Chemotherapy
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close